Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
Richard H Weisler,1,2 Lenard A Adler,3 Scott H Kollins,4 David W Goodman,5 Mohamed Hamdani,5 Bryan Dirks,6 Ann C Childress71Duke University Medical Center, Durham, NC, USA; 2University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 3New York University School of Medicine and Psychiatry Serv...
Guardado en:
Autores principales: | Weisler RH, Adler LA, Kollins SH, Goodman DW, Hamdani M, Dirks B, Childress AC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf9495663d5b4372aa6f74d234e8e445 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study
por: López F, et al.
Publicado: (2011) -
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial
por: Coghill DR, et al.
Publicado: (2014) -
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
por: Michael Pennick
Publicado: (2010) -
Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults
por: Ermer J, et al.
Publicado: (2013) -
Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges
por: Williams AE, et al.
Publicado: (2016)